Influence of urine pH and citrate concentration on the upper limit of metastability for calcium phosphateGREISCHAR, Amy; NAKAGAWA, Y; COE, Fredric L et al.The Journal of urology. 2003, Vol 169, Num 3, pp 867-870, issn 0022-5347, 4 p.Article

Evidence for durable kidney stone prevention over several decadesPARKS, Joan H; COE, Fredric L.BJU international (Papier). 2009, Vol 103, Num 9, pp 1238-1246, issn 1464-4096, 9 p.Article

Gender differences in seasonal variation of urine stone risk factorsPARKS, Joan H; BARSKY, Robert; COE, Fredric L et al.The Journal of urology. 2003, Vol 170, Num 2, pp 384-388, issn 0022-5347, 5 p., 1Article

Thiazide does not affect urine oxalate excretionPARKS, Joan H; COE, Fredric L.The Journal of urology. 2003, Vol 170, Num 2, pp 393-396, issn 0022-5347, 4 p., 1Article

Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuriaBERGSLAND, Kristin J; WORCESTER, Elaine M; COE, Fredric L et al.American journal of physiology. Renal physiology. 2013, Vol 74, Num 2, issn 1931-857X, F592-F599Article

Decreased renal function among adults with a history of nephrolithiasis : A study of NHANES IIIGILLEN, Daniel L; WORCESTER, Elaine M; COE, Fredric L et al.Kidney international. 2005, Vol 67, Num 2, pp 685-690, issn 0085-2538, 6 p.Article

Evidence against a contribution of conventional urine risk factors to de novo ESRD renal stonesSTANKUS, Nicole; WORCESTER, Elaine; HAMMES, Mary et al.Nephrology, dialysis, transplantation (Print). 2006, Vol 21, Num 3, pp 701-706, issn 0931-0509, 6 p.Article

Nephrolithiasis and increased blood pressure among females with high body mass indexGILLEN, Daniel L; COE, Fredric L; WORCESTER, Elaine M et al.American journal of kidney diseases. 2005, Vol 46, Num 2, pp 263-269, issn 0272-6386, 7 p.Article

Changes in urine volume accomplished by physicians treating nephrolithiasisPARKS, Joan H; GOLDFISCHER, Evan R; COE, Fredric L et al.The Journal of urology. 2003, Vol 169, Num 3, pp 863-866, issn 0022-5347, 4 p.Article

Evidence for increased renal tubule and parathyroid gland sensitivity to serum calcium in human idiopathic hypercalciuriaWORCESTER, Elaine M; BERGSLAND, Kristin J; GILLEN, Daniel L et al.American journal of physiology. Renal physiology. 2013, Vol 74, Num 3, issn 1931-857X, F853-F860Article

Characteristic differences in cephalic arch geometry for diabetic and non-diabetic ESRD patientsHAMMES, Mary S; BOGHOSIAN, Michael E; CASSEL, Kevin W et al.Nephrology, dialysis, transplantation (Print). 2009, Vol 24, Num 7, pp 2190-2194, issn 0931-0509, 5 p.Article

The role of Randall's plaques in the pathogenesis of calcium stonesMATLAGA, Brian R; COE, Fredric L; EVAN, Andrew P et al.The Journal of urology. 2007, Vol 177, Num 1, pp 31-38, issn 0022-5347, 8 p.Article

Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practiceMARDIS, Hal K; PARKS, Joan H; MULLER, Georg et al.The Journal of urology. 2004, Vol 171, Num 1, pp 85-88, issn 0022-5347, 4 p.Article

A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasisPARKS, Joan H; GOLDFISHER, Evan; ASPLIN, John R et al.The Journal of urology. 2002, Vol 167, Num 4, pp 1607-1612, issn 0022-5347Article

Reduced crystallization inhibition by urine from women with nephrolithiasisASPLIN, John R; PARKS, Joan H; NAKAGAWA, Yashushi et al.Kidney international. 2002, Vol 61, Num 5, pp 1821-1829, issn 0085-2538Article

Urine stone risk factors in nephrolithiasis patients with and without bowel diseasePARKS, Joan H; WORCESTER, Elaine M; O'CONNOR, R. Corey et al.Kidney international. 2003, Vol 63, Num 1, pp 255-265, issn 0085-2538, 11 p.Article

Solid phase assay of urine cystine supersaturation in the presence of cystine binding drugsCOE, Fredric L; CLARK, Cyndi; PARKS, Joan H et al.The Journal of urology. 2001, Vol 166, Num 2, pp 688-693, issn 0022-5347Article

Causes and consequences of kidney loss in patients with nephrolithiasisWORCESTER, Elaine; PARKS, Joan H; JOSEPHSON, Michelle A et al.Kidney international. 2003, Vol 64, Num 6, pp 2204-2213, issn 0085-2538, 10 p.Article

A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formersBERGSLAND, Kristin J; COE, Fredric L; GILLEN, Daniel L et al.American journal of physiology. Renal physiology. 2009, Vol 66, Num 4, issn 1931-857X, F1017-F1023Article

Proportional reduction of urine supersaturation during nephrolithiasis treatmentCOE, Fredric L; WISE, Henry; PARKS, Joan H et al.The Journal of urology. 2001, Vol 166, Num 4, pp 1247-1251, issn 0022-5347Conference Paper

Kidney stones: an update on current pharmacological management and future directionsHONGSHI XU; ZISMAN, Anna L; COE, Fredric L et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 4, pp 435-447, issn 1465-6566, 13 p.Article

Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuriaFAVUS, Murray J; KARNAUSKAS, Alexander J; PARKS, Joan H et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 10, pp 4937-4943, issn 0021-972X, 7 p.Article

Clinical use of cystine supersaturation measurementsNAKAGAWA, Y; ASPLIN, John R; GOLDFARB, David S et al.The Journal of urology. 2000, Vol 164, Num 5, pp 1481-1485, issn 0022-5347Article

Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidismPARKS, Joan H; COE, Fredric L; EVAN, Andrew P et al.BJU international (Papier). 2009, Vol 103, Num 5, pp 670-678, issn 1464-4096, 9 p.Article

Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with timePARKS, Joan H; COE, Fredric L; EVAN, Andrew P et al.Nephrology, dialysis, transplantation (Print). 2009, Vol 24, Num 1, pp 130-136, issn 0931-0509, 7 p.Article